These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37710185)

  • 1. BAP1 mutations inhibit the NF-κB signaling pathway to induce an immunosuppressive microenvironment in uveal melanoma.
    Zhang C; Wu S
    Mol Med; 2023 Sep; 29(1):126. PubMed ID: 37710185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITGB2-ICAM1 axis promotes liver metastasis in BAP1-mutated uveal melanoma with retained hypoxia and ECM signatures.
    Li J; Cao D; Jiang L; Zheng Y; Shao S; Zhuang A; Xiang D
    Cell Oncol (Dordr); 2024 Jun; 47(3):951-965. PubMed ID: 38150154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AMP-dependent kinase pathway is upregulated in BAP1 mutant uveal melanoma.
    Chua V; Han A; Bechtel N; Purwin TJ; Hunter E; Liao C; Harbour JW; Aplin AE
    Pigment Cell Melanoma Res; 2022 Jan; 35(1):78-87. PubMed ID: 34347929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma.
    Ewens KG; Kanetsky PA; Richards-Yutz J; Purrazzella J; Shields CL; Ganguly T; Ganguly A
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(8):5160-7. PubMed ID: 24970262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate dehydrogenase inactivation causes glycolytic phenotype in BAP1 mutant uveal melanoma.
    Han A; Chua V; Baqai U; Purwin TJ; Bechtel N; Hunter E; Tiago M; Seifert E; Speicher DW; Schug ZT; Harbour JW; Aplin AE
    Oncogene; 2022 Feb; 41(8):1129-1139. PubMed ID: 35046531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
    Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
    Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stress.
    Chua V; Lopez-Anton M; Mizue Terai ; Ryota Tanaka ; Baqai U; Purwin TJ; Haj JI; Waltrich FJ; Trachtenberg I; Luo K; Tudi R; Jeon A; Han A; Chervoneva I; Davies MA; Aguirre-Ghiso JA; Sato T; Aplin AE
    Sci Signal; 2024 Jun; 17(840):eadn8376. PubMed ID: 38861613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
    Han A; Purwin TJ; Bechtel N; Liao C; Chua V; Seifert E; Sato T; Schug ZT; Speicher DW; Harbour JW; Aplin AE
    Oncogene; 2021 Jan; 40(3):618-632. PubMed ID: 33208912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.
    Decatur CL; Ong E; Garg N; Anbunathan H; Bowcock AM; Field MG; Harbour JW
    JAMA Ophthalmol; 2016 Jul; 134(7):728-33. PubMed ID: 27123562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
    Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
    J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment.
    Gezgin G; Dogrusöz M; van Essen TH; Kroes WGM; Luyten GPM; van der Velden PA; Walter V; Verdijk RM; van Hall T; van der Burg SH; Jager MJ
    Cancer Immunol Immunother; 2017 Jul; 66(7):903-912. PubMed ID: 28391358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
    Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
    Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis of GNAQ, GNA11, BAP1, SF3B1,SRSF2, EIF1AX, PLCB4, and CYSLTR2 genes and their role in the pathogenesis of Uveal Melanoma.
    Akin-Bali DF
    Ophthalmic Genet; 2021 Dec; 42(6):732-743. PubMed ID: 34353217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic Disease in Polyploid Uveal Melanoma Patients Is Associated With BAP1 Mutations.
    Yavuzyigitoglu S; Mensink HW; Smit KN; Vaarwater J; Verdijk RM; Beverloo B; Brüggenwirth HT; van Marion R; Dubbink HJ; Paridaens D; Naus NC; de Klein A; Kiliç E;
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2232-9. PubMed ID: 27116551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.
    Field MG; Kuznetsov JN; Bussies PL; Cai LZ; Alawa KA; Decatur CL; Kurtenbach S; Harbour JW
    Clin Cancer Res; 2019 Sep; 25(18):5663-5673. PubMed ID: 31285370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Profiling of Metastatic Uveal Melanoma Shows Frequent Coexisting BAP1 or SF3B1 and GNAQ/GNA11 Mutations and Correlation With Prognosis.
    Isaacson AL; Sompallae RR; Guseva NV; Bellizzi AM; Bossler AD; Ma D
    Am J Clin Pathol; 2022 Aug; 158(2):177-186. PubMed ID: 35212356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
    Mergener S; Siveke JT; Peña-Llopis S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-occurrence of BAP1 and SF3B1 mutations in uveal melanoma induces cellular senescence.
    Yu L; Zhou D; Zhang G; Ren Z; Luo X; Liu P; Plouffe SW; Meng Z; Moroishi T; Li Y; Zhang Y; Brown JH; Liu S; Guan KL
    Mol Oncol; 2022 Feb; 16(3):607-629. PubMed ID: 34706158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.